U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H11FN2O5
Molecular Weight 246.1924
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-(2-DEOXY-2-FLUORO-.BETA.-D-ARABINOFURANOSYL)URACIL

SMILES

OC[C@H]1O[C@H]([C@@H](F)[C@@H]1O)N2C=CC(=O)NC2=O

InChI

InChIKey=UIYWFOZZIZEEKJ-PXBUCIJWSA-N
InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8-/m1/s1

HIDE SMILES / InChI
1-(2-DEOXY-2-FLUORO-β-D-ARABINOFURANOSYL)URACIL (FAU) is a thymidine analog. In several cancer cell lines, FAU was phosphorylated intracellularly to its monophosphate, 1-(2-deoxy-2-fluoro--Darabinofuranosyl) uracil monophosphate (FAUMP), by thymidine kinase and methylated in the 5-position by thymidylate synthase to form the product, 1-(2-deoxy-2-fluoro- -D-arabinofuranosyl) 5-methyluracil monophosphate (FMAUMP). FAU strongly inhibits the growth of tumor cells with high thymidylate synthase activity. FAU had been in phase I clinical trial for the treatment of advanced solid tumors.

CNS Activity

Curator's Comment: Known to be CNS penetrant in mouse. Human data not available.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1152 ng/mL
50 mg/m² 1 times / week multiple, intravenous
dose: 50 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
1-(2-DEOXY-2-FLUORO-.BETA.-D-ARABINOFURANOSYL)URACIL plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
1479 ng/mL
50 mg/m² single, intravenous
dose: 50 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
1-(2-DEOXY-2-FLUORO-.BETA.-D-ARABINOFURANOSYL)URACIL plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
4.1 ng/mL
50 mg/m² 1 times / week multiple, intravenous
dose: 50 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
FMAU plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
2.1 ng/mL
50 mg/m² single, intravenous
dose: 50 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
FMAU plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts.
1996 Apr 16
Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
2002 May
Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogs.
2003 Jan
Patents

Sample Use Guides

Mice: In 25% ethanol 5 ul/g (0.74 mg/kg (0.16 uCi/g))
Route of Administration: Intravenous
Coincubation of [3H]-FAU (43 nM/l) in vitro with 50 nmol/L FdUrd decreased FAU incorporation into DNA by 70% in HT29 and 84% in LS174T.
Name Type Language
1-(2-DEOXY-2-FLUORO-.BETA.-D-ARABINOFURANOSYL)URACIL
Common Name English
2'-F-ARA-DEOXYURIDINE
Common Name English
2,4(1H,3H)-PYRIMIDINEDIONE, 1-(2-DEOXY-2-FLUORO-.BETA.-D-ARABINOFURANOSYL)-
Common Name English
2'-FLUORO-ARA-DEOXYURIDINE
Common Name English
FAU
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1557
Created by admin on Fri Dec 15 17:22:16 GMT 2023 , Edited by admin on Fri Dec 15 17:22:16 GMT 2023
Code System Code Type Description
PUBCHEM
3007908
Created by admin on Fri Dec 15 17:22:16 GMT 2023 , Edited by admin on Fri Dec 15 17:22:16 GMT 2023
PRIMARY
FDA UNII
K7386OMP29
Created by admin on Fri Dec 15 17:22:16 GMT 2023 , Edited by admin on Fri Dec 15 17:22:16 GMT 2023
PRIMARY
NCI_THESAURUS
C80036
Created by admin on Fri Dec 15 17:22:16 GMT 2023 , Edited by admin on Fri Dec 15 17:22:16 GMT 2023
PRIMARY
CAS
69123-94-0
Created by admin on Fri Dec 15 17:22:16 GMT 2023 , Edited by admin on Fri Dec 15 17:22:16 GMT 2023
PRIMARY
NSC
678515
Created by admin on Fri Dec 15 17:22:16 GMT 2023 , Edited by admin on Fri Dec 15 17:22:16 GMT 2023
PRIMARY
EPA CompTox
DTXSID20219192
Created by admin on Fri Dec 15 17:22:16 GMT 2023 , Edited by admin on Fri Dec 15 17:22:16 GMT 2023
PRIMARY